Recruiting

NCT Number: NCT06910878

Urinary Tract Infections Caused by Extended-spectrum Beta-lactamase-producing Enterobacteria

Urinary tract infections (UTIs) are one of the most common pathologies encountered in general practice. However, with increasing bacterial resistance to antibiotics, their treatment is becoming increasingly complex. Extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-E) pose a particular challenge due to their increased resistance to many commonly used antibiotics. The aim of this thesis is to study the management of such infections by general practitioners in Bas-Rhin and to suggest possible avenues for improvement.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Urinary Tract Infections Female Urogenital Diseases Female Urogenital Diseases and Pregnancy Complications Infections Male Urogenital Diseases Urogenital Diseases Urologic Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Service de maladies infectieuses et tropicales - Hôpitaux Universitaires de Strasbourg

Strasbourg, France

Location status: Recruiting

Location contact

Claire SCHMITTBUHL, MD

SUB_INVESTIGATOR

Vanessa COCQUERELLE, PharmD

SUB_INVESTIGATOR

Yves HANSMANN, MD, PhD

CONTACT

[email protected]

33 3 69 55 09 78

Yves HANSMANN, MD, PhD

SUB_INVESTIGATOR

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Adult (≥18 years old)
Subject with an Enterobacteriaceae urinary tract infection treated in a primary care setting for urinary tract infection between June 1, 2024 and December 31, 2024
Subject not objecting, after being informed, to the reuse of their data for the purposes of this research.
The subject's primary care physician agreeing to participate in the study

Exclusion criteria

Subject and/or their primary care physician having expressed their opposition to participating in the study
Subject under legal protection
Subject under guardianship or curatorship

Treatment and study plan

Primary outcomes

Prescription rates of appropriate antibiotics for the treatment of ESBL-E UTIs

Time frame: Up to 1 year

Prescription rates of appropriate antibiotics for the treatment of ESBL-E UTIs by general practitioners compared to current health authority recommendations

Study contacts

Contact information is provided by the study sponsor or research team.

Yves HANSMANN, MD, PhD

CONTACT

[email protected]

33 3 69 55 09 78

Sponsors and collaborators

Lead sponsor

University Hospital, Strasbourg, France

Other

Registry information

Official study title

Urinary Tract Infections Caused by Extended-spectrum Beta-lactamase-producing Enterobacteria: Management by General Practitioners in Bas-Rhin.

Acronym: EBLSE

Important dates

Study start: 2024
Primary completion: 2025
Study completion: 2025
First posted: Apr 4, 2025
Registry last updated: Apr 4, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Recruiting